BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
RFK Jr. wants to scrutinize the vaccine schedule – but its safety record is already decades long - 2The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
- 3Vote In favor of Your Favored Kind Of Cheddar
- 4From Lounge chair to Money: Online Positions That Will Change Your Profession
- 5Zelensky warns of imminent massive Russian attack on Ukraine
- Deadly heat worldwide prompts $300 million for climate health research at COP30
- Vote in favor of the handheld vacuum that you love for its strong attractions!
- RFK Jr.'s vaccine panel delays hepatitis B shot vote after chaotic meeting
- Vinicultural Investigation: A Survey of \Enjoying Fine Vintages\ Wine sampling
- FDA approves Wegovy pill for weight loss: What to know
- EU Council president: Ukraine should receive binding guarantees
- Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Finding the Universe of Craftsmanship: Individual Encounters in Imagination
- Man triggers smoke bomb during failed crypto robbery
